"FDA approval"

Eli Lilly's acquisition of AtaiBeckley for up to $3.8 billion, marks a pivotal moment for psychedelic medicine.

The FDA approved Lipfendra (enlicitide), the first oral PCSK9 inhibitor, on July 16, 2026.

A first-in-class nanoparticle injection sneaks antibodies into pancreatic cancer cells to clear mutant KRAS, shrinking tumors in mice while...

A doctor breaks down a new study on how mRNA vaccines in melanoma research could transform treatment and survival for cancer patients

In this week’s edition of InnovationRx, we look at the boom in autoimmune disease therapies, OpenAI’s healthcare push, Vertex’s $10 billion...

Machine learning has unlocked significant value across the entire healthcare delivery lifecycle.

In this week’s edition of InnovationRx, we look at AbbVie’s new megadeal, an agentic AI startup saving Medicare $2 million a week, how new s...

Midjourney's Move Into Medicine Is A Bet On Data, Not Doctors

GLP-1 weight loss drugs like Ozempic, Zepbound and Wegovy are the biggest contributor to rising prescription spending. And that will trigger...

With an FDA panel expected to recommend legal production of as many as seven peptides this week, compounding pharmacies and telehealth compa...

These Alzheimer's tests raise many important issues that patients and their physicians should carefully consider before requesting or admini...

In this week’s edition of InnovationRx, we look at Axsome’s growing pipeline, HistoSonics innovative cancer treatment, state litigation over...